Merit Medical Systems Stock Price, News & Analysis (NASDAQ:MMSI)

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings or view top-rated stocks.

5 equities research analysts have issued 1 year target prices for Merit Medical Systems' stock. Their MMSI share price targets range from $70.00 to $96.00. On average, they expect the company's share price to reach $85.50 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price.
View analysts price targets for MMSI or view top-rated stocks among Wall Street analysts.

Merit Medical Systems' stock was trading at $70.62 at the start of the year. Since then, MMSI stock has increased by 3.0% and is now trading at $72.71.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our MMSI earnings forecast.

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its earnings results on Thursday, October, 26th. The medical instruments supplier reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.10. The medical instruments supplier earned $315.23 million during the quarter, compared to analysts' expectations of $306.25 million. Merit Medical Systems had a trailing twelve-month return on equity of 14.71% and a net margin of 8.17%.

ETFs with the largest weight of Merit Medical Systems (NASDAQ:MMSI) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), Emerge EMPWR Sustainable Select Growth Equity ETF (EMGC), Invesco S&P SmallCap Momentum ETF (XSMO), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Emerge EMPWR Unified Sustainable Equity ETF (EMPW), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), SPDR S&P 600 Small Cap Growth ETF (SLYG) and iShares S&P Small-Cap 600 Growth ETF (IJT).

Merit Medical Systems updated its FY23 earnings guidance on Thursday, October, 26th. The company provided earnings per share guidance of $2.93-2.99 for the period, compared to the consensus earnings per share estimate of $2.88. The company issued revenue guidance of $1.242-1.251 billion, compared to the consensus revenue estimate of $1.24 billion.

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Merit Medical Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (6.75%), Conestoga Capital Advisors LLC (3.71%), Fuller & Thaler Asset Management Inc. (2.41%), Loomis Sayles & Co. L P (1.79%), Morgan Stanley (1.59%) and Invesco Ltd. (1.30%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, F Ann Millner, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Michel James Voigt, Neil Peterson, Raul Jr Parra and Ronald Frost.
View institutional ownership trends.

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.